RetinalGeniX Technologies Inc. Appoints Dessy Boneva, MD, FACS to the Board of Directors
PETALUMA, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX Technologies Inc. (OTCQB: RTGN) (“RetinalGeniX” or the “Company”), today announced that Dessislava (Dessy) Boneva, M.D.
- PETALUMA, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX Technologies Inc. (OTCQB: RTGN) (“RetinalGeniX” or the “Company”), today announced that Dessislava (Dessy) Boneva, M.D.
- RetinalGeniX is an ophthalmic research and development med-device and therapeutic drug development company focused on developing High-Resolution Retinal Imaging and Pharmaco-Genetic Mapping™ technologies.
- Dr. Boneva said, “I am very excited about joining the RetinalGeniX Board of Directors.
- Jerry Katzman MD, Chairman, President, and CEO of RetinalGeniX Technologies Inc., said, “We are delighted to welcome Dessy aboard.